Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Jan 29;286(6362):365–368. doi: 10.1136/bmj.286.6362.365

Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?

G R Venning
PMCID: PMC1546909  PMID: 6402104

Full text

PDF
365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews K., Brocklehurst J. C., Richards B., Laycock P. J. Stroke: does side matter? Rheumatol Rehabil. 1982 Aug;21(3):175–178. doi: 10.1093/rheumatology/21.3.175. [DOI] [PubMed] [Google Scholar]
  2. Benner E. J., Tellman W. H. Pseudomembraneous colitis as a sequel to oral lincomycin therapy. Am J Gastroenterol. 1970 Jul;54(1):55–58. [PubMed] [Google Scholar]
  3. Cohen L. E., McNeill C. J., Wells R. F. Clindamycin-associated colitis. JAMA. 1973 Mar 19;223(12):1379–1380. [PubMed] [Google Scholar]
  4. EY H., FAURE H., RAPPARD P. Les réactions d'intolérance vis-à-vis de la chlorpromazine. Encephale. 1956;45(4):790–796. [PubMed] [Google Scholar]
  5. FINNEY D. J. THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE. J Chronic Dis. 1965 Jan;18:77–98. doi: 10.1016/0021-9681(65)90054-8. [DOI] [PubMed] [Google Scholar]
  6. Geddes A. M., Bridgwater F. A., Williams D. N., Oon J., Grimshaw G. J. Clinical and bacteriological studies with clindamycin. Br Med J. 1970 Jun 20;2(5711):703–704. doi: 10.1136/bmj.2.5711.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HALL R. A., JACKSON R. B., SWAIN J. M. Neurotoxic reactions resulting from chlorpromazine administration. J Am Med Assoc. 1956 May 19;161(3):214–218. doi: 10.1001/jama.1956.02970030032008. [DOI] [PubMed] [Google Scholar]
  8. Inman W. H., Adelstein A. M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969 Aug 9;2(7615):279–285. doi: 10.1016/s0140-6736(69)90051-8. [DOI] [PubMed] [Google Scholar]
  9. Inman W. H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J. 1977 Jun 11;1(6075):1500–1505. doi: 10.1136/bmj.1.6075.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KLOTZ A. P., PALMER W. L., KIRSNER J. B. Aureomycin proctitis and colitis: a report of five cases. Gastroenterology. 1953 Sep;25(1):44–47. [PubMed] [Google Scholar]
  11. Karch F. E., Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977 Mar;21(3):247–254. doi: 10.1002/cpt1977213247. [DOI] [PubMed] [Google Scholar]
  12. LEONARD J. C. Toxic effects of phenylbutazone with special reference to disorders of the blood. Br Med J. 1953 Jun 13;1(4823):1311–1313. doi: 10.1136/bmj.1.4823.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lazare A., Klerman G. L. Hysteria and depression: the frequency and significance of hysterical personality features in hospitalized depressed women. Am J Psychiatry. 1968 May;124(11 Suppl):48–56. doi: 10.1176/ajp.124.8S.48. [DOI] [PubMed] [Google Scholar]
  14. MCCARTHY D. D., CHALMERS T. M. HEMATOLOGICAL COMPLICATIONS OF PHENYLBUTAZONE THERAPY: REVIEW OF THE LITERATURE AND REPORT OF TWO CASES. Can Med Assoc J. 1964 May 2;90:1061–1067. [PMC free article] [PubMed] [Google Scholar]
  15. Mann J. I., Inman W. H., Thorogood M. Oral contraceptive use in older women and fatal myocardial infarction. Br Med J. 1976 Aug 21;2(6033):445–447. doi: 10.1136/bmj.2.6033.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McGehee R. F., Jr, Smith C. B., Wilcox C., Finland M. Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci. 1968 Nov;256(5):279–292. doi: 10.1097/00000441-196811000-00002. [DOI] [PubMed] [Google Scholar]
  17. Price D. J., O'Grady F. W., Shooter R. A., Weaver P. C. Trial of phenoxymethylpenicillin, phenethicillin, and lincomycin in treatment of staphylococcal sepsis in a casualty department. Br Med J. 1968 Aug 17;3(5615):407–409. doi: 10.1136/bmj.3.5615.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. REINER L., SCHLESINGER M. J., MILLER G. M. Pseudomembranous colitis following aureomycin and chloramphenicol. AMA Arch Pathol. 1952 Jul;54(1):39–67. [PubMed] [Google Scholar]
  19. Scott A. J., Nicholson G. I., Kerr A. R. Lincomycin as a cause of pseudomembranous colitis. Lancet. 1973 Dec 1;2(7840):1232–1234. doi: 10.1016/s0140-6736(73)90973-2. [DOI] [PubMed] [Google Scholar]
  20. Shimkin P. M., Link R. J. Pseudomembranous colitis: a consideration in the barium enema differential diagnosis of acute generalized ulcerative colitis. Br J Radiol. 1973 Jun;46(546):437–439. doi: 10.1259/0007-1285-46-546-437. [DOI] [PubMed] [Google Scholar]
  21. Skegg D. C., Doll R. Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet. 1977 Sep 3;2(8036):475–478. doi: 10.1016/s0140-6736(77)91602-6. [DOI] [PubMed] [Google Scholar]
  22. Skegg D. C., Doll R. The case for recording events in clinical trials. Br Med J. 1977 Dec 10;2(6101):1523–1524. doi: 10.1136/bmj.2.6101.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tedesco F. J., Stanley R. J., Alpers D. H. Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med. 1974 Apr 11;290(15):841–843. doi: 10.1056/NEJM197404112901508. [DOI] [PubMed] [Google Scholar]
  24. Venning G. R. Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide? Br Med J (Clin Res Ed) 1983 Jan 15;286(6360):199–202. doi: 10.1136/bmj.286.6360.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Venning G. R. Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms. Br Med J (Clin Res Ed) 1982 Jan 23;284(6311):249–252. doi: 10.1136/bmj.284.6311.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J. 1968 Apr 27;2(5599):199–205. doi: 10.1136/bmj.2.5599.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wallerstein R. O., Condit P. K., Kasper C. K., Brown J. W., Morrison F. R. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA. 1969 Jun 16;208(11):2045–2050. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES